vs
Embecta Corp.（EMBC）与Gaming & Leisure Properties, Inc.（GLPI）财务数据对比。点击上方公司名可切换其他公司
Gaming & Leisure Properties, Inc.的季度营收约是Embecta Corp.的1.6倍（$420.0M vs $261.2M），Gaming & Leisure Properties, Inc.净利率更高（57.0% vs 16.9%，领先40.1%），Gaming & Leisure Properties, Inc.同比增速更快（6.3% vs -0.3%），过去两年Gaming & Leisure Properties, Inc.的营收复合增速更高（5.0% vs -4.6%）
Embecta Corp.是一家专注于糖尿病护理领域的全球医疗科技企业，主要设计、生产及销售胰岛素笔针、注射器、输注组件等给药装置，产品服务覆盖全球多个地区的患者、医疗机构及生物制药合作方。
博彩与休闲地产公司（GLPI）是一家专注于赌场物业的房地产投资信托（REIT），总部位于宾夕法尼亚州怀奥米辛。公司于2013年11月从宾州国民娱乐分拆成立，目前持有62处赌场物业，全部对外出租给其他企业运营。
EMBC vs GLPI — 直观对比
营收规模更大
GLPI
是对方的1.6倍
$261.2M
营收增速更快
GLPI
高出6.5%
-0.3%
净利率更高
GLPI
高出40.1%
16.9%
两年增速更快
GLPI
近两年复合增速
-4.6%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $261.2M | $420.0M |
| 净利润 | $44.1M | $239.4M |
| 毛利率 | 61.9% | — |
| 营业利润率 | 31.9% | 79.4% |
| 净利率 | 16.9% | 57.0% |
| 营收同比 | -0.3% | 6.3% |
| 净利润同比 | — | 40.5% |
| 每股收益（稀释后） | $0.74 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EMBCGLPI
| Q1 26 | — | $420.0M | ||
| Q4 25 | $261.2M | $407.0M | ||
| Q3 25 | $264.0M | $397.6M | ||
| Q2 25 | $295.5M | $394.9M | ||
| Q1 25 | $259.0M | $395.2M | ||
| Q4 24 | $261.9M | $389.6M | ||
| Q3 24 | $286.1M | $385.3M | ||
| Q2 24 | $272.5M | $380.6M |
净利润EMBCGLPI
| Q1 26 | — | $239.4M | ||
| Q4 25 | $44.1M | $275.4M | ||
| Q3 25 | $26.4M | $241.2M | ||
| Q2 25 | $45.5M | $151.4M | ||
| Q1 25 | $23.5M | $165.2M | ||
| Q4 24 | $0 | $223.6M | ||
| Q3 24 | $14.6M | $184.7M | ||
| Q2 24 | $14.7M | $208.3M |
毛利率EMBCGLPI
| Q1 26 | — | — | ||
| Q4 25 | 61.9% | — | ||
| Q3 25 | 60.0% | — | ||
| Q2 25 | 66.7% | — | ||
| Q1 25 | 63.4% | — | ||
| Q4 24 | 60.0% | — | ||
| Q3 24 | 60.7% | — | ||
| Q2 24 | 69.8% | — |
营业利润率EMBCGLPI
| Q1 26 | — | 79.4% | ||
| Q4 25 | 31.9% | 89.3% | ||
| Q3 25 | 21.4% | 84.8% | ||
| Q2 25 | 31.8% | 61.3% | ||
| Q1 25 | 24.3% | 65.5% | ||
| Q4 24 | 11.0% | 79.1% | ||
| Q3 24 | 9.2% | 70.4% | ||
| Q2 24 | 20.5% | 77.1% |
净利率EMBCGLPI
| Q1 26 | — | 57.0% | ||
| Q4 25 | 16.9% | 67.6% | ||
| Q3 25 | 10.0% | 60.7% | ||
| Q2 25 | 15.4% | 38.4% | ||
| Q1 25 | 9.1% | 41.8% | ||
| Q4 24 | — | 57.4% | ||
| Q3 24 | 5.1% | 47.9% | ||
| Q2 24 | 5.4% | 54.7% |
每股收益（稀释后）EMBCGLPI
| Q1 26 | — | — | ||
| Q4 25 | $0.74 | $0.96 | ||
| Q3 25 | $0.44 | $0.85 | ||
| Q2 25 | $0.78 | $0.54 | ||
| Q1 25 | $0.40 | $0.60 | ||
| Q4 24 | $0.00 | $0.79 | ||
| Q3 24 | $0.24 | $0.67 | ||
| Q2 24 | $0.25 | $0.77 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $201.3M | $274.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-613.1M | $5.0B |
| 总资产 | $1.1B | $13.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EMBCGLPI
| Q1 26 | — | $274.5M | ||
| Q4 25 | $201.3M | — | ||
| Q3 25 | $225.5M | — | ||
| Q2 25 | $230.6M | — | ||
| Q1 25 | $209.3M | — | ||
| Q4 24 | $210.0M | $560.8M | ||
| Q3 24 | $267.5M | $560.8M | ||
| Q2 24 | $275.1M | $560.8M |
总债务EMBCGLPI
| Q1 26 | — | — | ||
| Q4 25 | — | $7.2B | ||
| Q3 25 | $1.4B | $7.2B | ||
| Q2 25 | — | $6.9B | ||
| Q1 25 | — | $6.9B | ||
| Q4 24 | — | $7.7B | ||
| Q3 24 | $1.6B | $7.4B | ||
| Q2 24 | — | $6.6B |
股东权益EMBCGLPI
| Q1 26 | — | $5.0B | ||
| Q4 25 | $-613.1M | $4.6B | ||
| Q3 25 | $-650.6M | $4.6B | ||
| Q2 25 | $-669.6M | $4.6B | ||
| Q1 25 | $-736.2M | $4.2B | ||
| Q4 24 | $-768.8M | $4.3B | ||
| Q3 24 | $-738.3M | $4.3B | ||
| Q2 24 | $-763.7M | $4.1B |
总资产EMBCGLPI
| Q1 26 | — | $13.8B | ||
| Q4 25 | $1.1B | $12.9B | ||
| Q3 25 | $1.1B | $12.8B | ||
| Q2 25 | $1.2B | $12.5B | ||
| Q1 25 | $1.1B | $12.1B | ||
| Q4 24 | $1.1B | $13.1B | ||
| Q3 24 | $1.3B | $12.7B | ||
| Q2 24 | $1.3B | $11.8B |
负债/权益比EMBCGLPI
| Q1 26 | — | — | ||
| Q4 25 | — | 1.56× | ||
| Q3 25 | — | 1.57× | ||
| Q2 25 | — | 1.51× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.81× | ||
| Q3 24 | — | 1.74× | ||
| Q2 24 | — | 1.60× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.2M | — |
| 自由现金流经营现金流 - 资本支出 | $16.6M | — |
| 自由现金流率自由现金流/营收 | 6.4% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | 0.39× | — |
| 过去12个月自由现金流最近4个季度 | $205.8M | — |
8季度趋势，按日历期对齐
经营现金流EMBCGLPI
| Q1 26 | — | — | ||
| Q4 25 | $17.2M | $1.1B | ||
| Q3 25 | $84.0M | $240.3M | ||
| Q2 25 | $81.2M | $293.4M | ||
| Q1 25 | $31.8M | $252.5M | ||
| Q4 24 | $-5.3M | $1.1B | ||
| Q3 24 | $26.6M | $270.4M | ||
| Q2 24 | $-2.1M | $252.1M |
自由现金流EMBCGLPI
| Q1 26 | — | — | ||
| Q4 25 | $16.6M | — | ||
| Q3 25 | $76.7M | $183.0M | ||
| Q2 25 | $80.8M | $272.3M | ||
| Q1 25 | $31.7M | $239.6M | ||
| Q4 24 | $-6.8M | $1.1B | ||
| Q3 24 | — | $261.5M | ||
| Q2 24 | $-11.8M | $245.0M |
自由现金流率EMBCGLPI
| Q1 26 | — | — | ||
| Q4 25 | 6.4% | — | ||
| Q3 25 | 29.1% | 46.0% | ||
| Q2 25 | 27.3% | 69.0% | ||
| Q1 25 | 12.2% | 60.6% | ||
| Q4 24 | -2.6% | 275.3% | ||
| Q3 24 | — | 67.9% | ||
| Q2 24 | -4.3% | 64.4% |
资本支出强度EMBCGLPI
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | — | ||
| Q3 25 | 2.8% | 14.4% | ||
| Q2 25 | 0.1% | 5.3% | ||
| Q1 25 | 0.0% | 3.3% | ||
| Q4 24 | 0.6% | 0.0% | ||
| Q3 24 | 0.0% | 2.3% | ||
| Q2 24 | 3.6% | 1.9% |
现金转化率EMBCGLPI
| Q1 26 | — | — | ||
| Q4 25 | 0.39× | 4.10× | ||
| Q3 25 | 3.18× | 1.00× | ||
| Q2 25 | 1.78× | 1.94× | ||
| Q1 25 | 1.35× | 1.53× | ||
| Q4 24 | — | 4.80× | ||
| Q3 24 | 1.82× | 1.46× | ||
| Q2 24 | -0.14× | 1.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EMBC
| Pen Needles | $185.5M | 71% |
| Safety | $37.3M | 14% |
| Syringes | $30.7M | 12% |
| Manufacturing Facility | $4.1M | 2% |
GLPI
暂无分部数据
